Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma.
Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma.
复制标题
DOI:
10.1007/978-1-4613-1261-1_3
复制
发表时间:
1996
影响因子:
--
通讯作者:
John Calvin Reed;T. Miyashita;S. Krajewski;S. Takayama;C. Aimé-sempé;S. Kitada;T. Sato;H. G. Wang;M. Harigai;M. Hanada;M. Krajewska;K. Kochel;J. Millán;H. Kobayashi
中科院分区:
文献类型:
--
作者:
John Calvin Reed;T. Miyashita;S. Krajewski;S. Takayama;C. Aimé-sempé;S. Kitada;T. Sato;H. G. Wang;M. Harigai;M. Hanada;M. Krajewska;K. Kochel;J. Millán;H. Kobayashi
Members of the bcl-2 gene family playa central role in regulating the relative sensitivity and resistance of cells to a wide variety of apoptotic stimuli. The first member of this multigene family, bcl-2, was discovered by virtue of its involvement in the t (14; 18) chromosomal translocations commonly found in non-Hodgkin's lymphomas [1-4]. Deregulation of the bcl-2 gene either by translocations in B-cell lymphomas or through other mechanisms in several other types of cancer, including acute and chronic leukemias, contributes to neoplastic cell expansion by prolonging cell survival rather than by accelerating rates of cell division [5-8]. The Bcl-2 protein also can protect tumor cells from apoptosis induced by radiation and nearly all cytotoxic anticancer drugs [9-12], thus potentially contributing to treatment failures in patients with cancer [13-16]. Several additional homologues of bcl-2 have recently been discovered in humans and other mammals, revealing the presence of a multigene family [17-20]. Moreover, homologues of bcl-2 have been discovered in some DNA viruses, including Epstein-Barr virus (EBV), which plays a significant role in the pathogenesis of some types of non-Hodgkin's lymphomas and Hodgkin's disease [21]. Interestingly, some members of the bcl-2 gene family function as inhibitors of cell death, similar to bcl-2, whereas others are promoters of apoptosis that oppose the actions of the Bcl-2 protein. Many of these Bcl-2 family proteins have the capacity to interact with each other through formation of homo-and heterotypic dimers [17, 22], revealing an important role for protein-protein interactions in the orchastration of Bcl-2 family protein function and suggesting approaches to pharmacologically manipulating the physiological cell death pathway (see table 1).